程序性死亡蛋白-1抑制劑相關葡萄膜炎3例_Chinese Journal of Ocular Fundus Diseases

Authors：

葛瑤 ¹ , 李麗杰 ² , 龐惠文 ¹ , 揭姍姍 ¹ , 邰仁清 ¹ , 高宏程 ³ ,  陳晨 ³ , 王偉 ³

1. ;
2. ;
3. ;

Corresponding?author：

陳晨, Email: sdchenchen@126.com

Keywords：

程序性死亡蛋白-1抑制劑; 葡萄膜炎; 藥物不良反應; 病例報告

DOI：

10.3760/cma.j.cn511434-20250630-00290

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 葛瑤, 李麗杰, 龐惠文, 揭姍姍, 邰仁清, 高宏程, 陳晨, 王偉. 程序性死亡蛋白-1抑制劑相關葡萄膜炎3例. Chinese Journal of Ocular Fundus Diseases, 2026, 42(3): 243-245. doi: 10.3760/cma.j.cn511434-20250630-00290 Copy

1.
2.
3.
4.
5.
6.	Baughman DM, Lee CS, Snydsman BE, et al. Bilateral uveitis and keratitis following nivolumab treatment for metastatic melanoma[J/OL]. Med Case Rep (Wilmington), 2017, 3(2): 8[2017-04-14]. https://pubmed.ncbi.nlm.nih.gov/28856338/. DOI: 10.21767/2471-8041.100044.
7.	Hanna KS. A rare case of pembrolizumab-induced uveitis in a patient with metastatic melanoma[J/OL]. Pharmacotherapy, 2016, 36(11): e183-e188[2016-10-26]. https://pubmed.ncbi.nlm.nih.gov/27716999/. DOI: 10.1002/phar.1839.
8.
9.

1.
2.
3.
4.
5.
6. Baughman DM, Lee CS, Snydsman BE, et al. Bilateral uveitis and keratitis following nivolumab treatment for metastatic melanoma[J/OL]. Med Case Rep (Wilmington), 2017, 3(2): 8[2017-04-14]. https://pubmed.ncbi.nlm.nih.gov/28856338/. DOI: 10.21767/2471-8041.100044.
7. Hanna KS. A rare case of pembrolizumab-induced uveitis in a patient with metastatic melanoma[J/OL]. Pharmacotherapy, 2016, 36(11): e183-e188[2016-10-26]. https://pubmed.ncbi.nlm.nih.gov/27716999/. DOI: 10.1002/phar.1839.
8.
9.

Previous Article
弓形蟲脈絡膜視網膜炎1例
Next Article
地塞米松植入劑多次異位于前房1例

Chinese Journal of Ocular Fundus Diseases

程序性死亡蛋白-1抑制劑相關葡萄膜炎3例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content